These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 36170293)

  • 1. Assessing the effectiveness of COVID-19 vaccine lotteries: A cross-state synthetic control methods approach.
    Fuller S; Kazemian S; Algara C; Simmons DJ
    PLoS One; 2022; 17(9):e0274374. PubMed ID: 36170293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implementation of State Vaccine Incentive Lottery Programs and Uptake of COVID-19 Vaccinations in the United States.
    Acharya B; Dhakal C
    JAMA Netw Open; 2021 Dec; 4(12):e2138238. PubMed ID: 34882179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing the Impact of Vaccine Lotteries on COVID-19 Vaccination Rates in the United States in 2021.
    Sload J; Bechtolsheim B; Gifford D
    Am J Public Health; 2022 Aug; 112(8):1130-1133. PubMed ID: 35737921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between statewide financial incentive programs and COVID-19 vaccination rates.
    Thirumurthy H; Milkman KL; Volpp KG; Buttenheim AM; Pope DG
    PLoS One; 2022; 17(3):e0263425. PubMed ID: 35353815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Everyone Wins: Vaccine Lotteries Can Cost-Effectively Increase COVID-19 Booster Vaccination Rates.
    McLaren ZM
    Am J Epidemiol; 2023 Apr; 192(4):510-513. PubMed ID: 36642497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conditional cash lotteries increase COVID-19 vaccination rates.
    Barber A; West J
    J Health Econ; 2022 Jan; 81():102578. PubMed ID: 34986437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can financial incentives and other nudges increase COVID-19 vaccinations among the vaccine hesitant? A randomized trial.
    Jacobson M; Chang TY; Shah M; Pramanik R; Shah SB
    Vaccine; 2022 Oct; 40(43):6235-6242. PubMed ID: 36137900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effectiveness of financial incentives for COVID-19 vaccination: A systematic review.
    Khazanov GK; Stewart R; Pieri MF; Huang C; Robertson CT; Schaefer KA; Ko H; Fishman J
    Prev Med; 2023 Jul; 172():107538. PubMed ID: 37156430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Motivations to Vaccinate Among Hesitant Adopters of the COVID-19 Vaccine.
    Moore R; Purvis RS; Hallgren E; Willis DE; Hall S; Reece S; CarlLee S; Judkins H; McElfish PA
    J Community Health; 2022 Apr; 47(2):237-245. PubMed ID: 34687388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quasi-experimental evaluation of a financial incentive for first-dose COVID-19 vaccination among adults aged ≥60 years in South Africa.
    Chetty-Makkan CM; Thirumurthy H; Bair EF; Bokolo S; Day C; Wapenaar K; Werner J; Long L; Maughan-Brown B; Miot J; Pascoe SJS; Buttenheim AM
    BMJ Glob Health; 2022 Dec; 7(12):. PubMed ID: 36543383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Children, vaccines, and financial incentives.
    Erdem O; Erdem S; Monson K
    Int J Health Econ Manag; 2023 Dec; 23(4):537-552. PubMed ID: 36853572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Financial incentives for vaccination do not have negative unintended consequences.
    Schneider FH; Campos-Mercade P; Meier S; Pope D; Wengström E; Meier AN
    Nature; 2023 Jan; 613(7944):526-533. PubMed ID: 36631607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative effectiveness of mandates and financial policies targeting COVID-19 vaccine hesitancy: A randomized, controlled survey experiment.
    Fishman J; Salmon MK; Scheitrum D; Aleks Schaefer K; Robertson CT
    Vaccine; 2022 Dec; 40(51):7451-7459. PubMed ID: 35914961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are vaccine lotteries worth the money?
    Robertson C; Schaefer KA; Scheitrum D
    Econ Lett; 2021 Dec; 209():110097. PubMed ID: 35153345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COVID-19 Vaccine Hesitancy: A Critical Time Period Analysis.
    Kues JR; Knapke JM; Elshaer S; Mendell AM; Hildreth L; Schuckman SM; Wijesooriya J; Butsch Kovacic M
    Int J Environ Res Public Health; 2022 Jul; 19(13):. PubMed ID: 35805757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of framing and communicating COVID-19 vaccine side-effect risks on vaccine intentions for adults in the UK and the USA: A structured summary of a study protocol for a randomized controlled trial.
    Sudharsanan N; Favaretti C; Hachaturyan V; Bärnighausen T; Vandormael A
    Trials; 2021 Sep; 22(1):592. PubMed ID: 34488843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cable news and COVID-19 vaccine uptake.
    Pinna M; Picard L; Goessmann C
    Sci Rep; 2022 Oct; 12(1):16804. PubMed ID: 36207425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effective incentives for increasing COVID-19 vaccine uptake.
    Salali GD; Uysal MS
    Psychol Med; 2023 May; 53(7):3242-3244. PubMed ID: 34538287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incentivizing COVID-19 Vaccination in a Polarized and Partisan United States.
    Algara C; Simmons DJ
    J Health Polit Policy Law; 2023 Oct; 48(5):679-712. PubMed ID: 36995366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Motivations for Vaccine Hesitancy Among EMS Providers in the United States who Declined the COVID-19 Vaccine.
    Shekhar AC; Hannan DJ
    Prehosp Disaster Med; 2022 Apr; 37(2):269-272. PubMed ID: 35168692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.